Results 141 to 150 of about 297,952 (346)

Epidemiological approaches to evaluate clinical unmasking of HPV‐associated cervical lesions in the HPV vaccination era

open access: yesInternational Journal of Cancer, EarlyView.
Abstract HPV vaccination reduces the risk of developing HPV‐attributable cancers, including cervical cancer. However, an attenuation of HPV vaccine impact after the implementation of HPV vaccination may occur through clinical unmasking. Clinical unmasking is a distinct and complex phenomenon that arises in the absence of clinical interventions ...
Joseph E. Tota   +8 more
wiley   +1 more source

Harnessing viral footprints in circulating free DNA (cfDNA) for early cancer detection: A focus on liquid‐biopsy‐based screening

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Viral infections play a significant role in cancer development, making detecting viral signatures a promising approach for early cancer diagnosis. Circulating free DNA (cfDNA), released into the bloodstream by tumors and other cells, has emerged as a powerful biomarker for non‐invasive cancer screening.
Richard Donkor Amponsah   +4 more
wiley   +1 more source

Transitioning from HPV 101 to HPV 202 [PDF]

open access: yesAmerican Journal of Obstetrics and Gynecology, 2017
Richard S. Guido, Warner K. Huh
openaire   +3 more sources

Developing an HPV Infection Risk Prediction Model for Adult Females [PDF]

open access: yes, 2018
According to the Centers for Disease Control and Prevention (CDC), nearly one in four people are currently infected with human papillomavirus (HPV) in the United States.
Holmer, Rachel
core   +2 more sources

Long‐term human papillomavirus genotype‐specific risk of cervical high‐grade intraepithelial lesion and cancer—By age group and triage cytology

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Human papillomavirus (HPV) testing has revolutionized cervical cancer screening. Nonetheless, its optimal use for distinguishing between high‐ and low‐risk infections to leverage screening benefits remains to be established. Here, long‐term HPV genotype‐specific risk of precancerous cervical intraepithelial neoplasia grade 2 or higher was ...
Maija Vahteristo   +6 more
wiley   +1 more source

Control of HPV-associated cancers with HPV vaccination [PDF]

open access: yesThe Lancet Infectious Diseases, 2017
Mark Schiffman, Mona Saraiya
openaire   +3 more sources

Kissing: Hullo hpv

open access: yesCurrent Oncology, 2011
There are at least 5 types of kisses, including ges-tural, cultural, osculum, basium, saviolum, and oro-genital.[...]
openaire   +2 more sources

Trends in cervical cancer incidence in the Netherlands: A join‐point and age–period–cohort analysis (1989–2023)

open access: yesInternational Journal of Cancer, EarlyView.
What's New? This ecological study of trends in cervical cancer incidence from 1989 to 2023 in the Netherlands indicates a positive impact of screening, with a steady decline over the years. However, incidence increased from 2003 to 2023, particularly among younger cohorts, aligning with reduced participation and the introduction of more sensitive, high‐
Kelly Melisa Castañeda   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy